STXS
$2.75
Stereotaxis
($.02)
(.72%)
STXS
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Tuesday
Jun 9
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when STXS reports earnings?
Beat
Meet
Miss

Where is STXS's stock price going from here?
Up
Flat
Down
Stock chart of STXS
Analysts
Summary of analysts' recommendations for STXS
Score
Grade
Pivots
Resistance
$3.40
$3.14
$2.95

$2.69

Support
$2.50
$2.24
$2.05
Tweet
Growth
Description
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites.